Newborn screening is the only practical means of diagnosing MLD prior to the onset of symptoms, which is key to achieving optimal outcomes for children and their families with this rapidly progressive disease As of today, 14 states—representing more than 50 percent of U.S. births—have RUSP-aligned legislation intended to expedite the addition of newly approved RUSP conditions to their respective NBS panels Other community-led efforts to enable newborn screening for MLD advancing globally TOKYO, LONDON and B ...